Neurobehavioral effects of Δ9-THC and cannabinoid (CB1) receptor gene expression in mice

Abood, 1992, Neurobiology of marijuana abuse, Trends Phamacol. Sci., 13, 201, 10.1016/0165-6147(92)90064-D Bouaboula, 1993, Cannabinoid receptor expression in human leukocytes, Eur. J. Biochem., 214, 173, 10.1111/j.1432-1033.1993.tb17910.x Chaudhuri, 1994, Characterization of the transcriptional initiation sites of the brain-type and the peripheral-type human cannabinoid receptor genes, J. Celluar Biochem., 18C, 16 Chen, 1991, Strain-specific facilitation of dopamine efflux by Δ9-tetrahydrocannabinol in the nucleus accumbens of rat: an in vivo microdialysis study, Neurosci. Lett., 129, 136, 10.1016/0304-3940(91)90739-G Commissaris, 1989, MR/HAR and MNRA/HAR Maudsley rat strains: differential response to chlordiazepoxide in a conflict task, Pharmacol. Biochem. Behav., 32, 801, 10.1016/0091-3057(89)90037-3 Costall, 1990, Sites of action of odansetron to inhibit withdrawal from drugs of abuse, Pharmacol. Biochem. Behav., 36, 97, 10.1016/0091-3057(90)90132-2 Costall, 1989, Neuroanatomical sites of action of 5-HT3 receptor agonist and antagonists for alteration of aversive behavior in the mouse, Br. J. Pharmacol., 96, 325, 10.1111/j.1476-5381.1989.tb11821.x D'Amour, 1941, A method for determining loss of pain sensation, J. Pharmacol. Exp. Ther., 72, 74 Davis, 1992, The role of the amygdala in fear and anxiety, Annu. Rev. Neurosci., 25, 353, 10.1146/annurev.ne.15.030192.002033 Detke, 1988, DNA amplification in tunicamycin resistant Leishmania mexicana: multicopies of a single 63 kilobase supercoiled molecule and their expression, J. Biol. Chem., 263, 3418, 10.1016/S0021-9258(18)69087-8 Deutsch, 1993, Enzymatic synthesis of anandamide, a cannabinoid receptor agonist, Biochem. Pharmacol., 46, 791, 10.1016/0006-2952(93)90486-G Devane, 1992, Isolation and structure of a brain constituent that binds to the cannabinoid receptor, Science, 258, 1946, 10.1126/science.1470919 Dewey, 1970, The effect of various neurohumoral modulators on the activity of morphine and the narcotic antagonists in the tail-flick and phenylquinone test, J. Pharmacol. Exp. Ther., 175, 435 Foltin, 1988, Effects of smoked marijuana on human social behavior in small groups, Pharmacol. Biochem. Behav., 30, 539, 10.1016/0091-3057(88)90494-7 Gardner, 1988, Strain-specific facilitation of reward by Δ-tetrahydrocannobinol in laboratory rats, Psychopharmacology, 96, 365, 10.1007/BF02431546 Gerard, 1991, Molecular cloning of a human cannobinoid receptor which is also expressed in testis, Biochem. J., 279, 129, 10.1042/bj2790129 Gora-Maslak, 1991, Use of recombinant inbred strains to identify quantitative trait loci in psychopharmacology, Psychopharmacology, 104, 413, 10.1007/BF02245643 Green, 1991, Biochemical mechanisms of constitutive and regulated pre-mRNA splicing, Annu. Rev. Cell Biol., 7, 559, 10.1146/annurev.cb.07.110191.003015 Herkenham, 1991, Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study, J. Neurosci., 11, 563, 10.1523/JNEUROSCI.11-02-00563.1991 Iversen, 1993, Medical uses of marijuana?, Nature, 365, 12, 10.1038/365012a0 Jackson, 1990, Body temperature discriminates between full and partial benzodiazepine receptor antagonists, Eur. J. Pharmacol., 185, 243, 10.1016/0014-2999(90)90649-Q Joshi, 1992, Hypothermia due to transient hypothalamic dysfunction in tuberculous meningitis with hydrocephalus, Br. J. Neurosurg., 6, 385, 10.3109/02688699209023801 Lambowitz, 1993, Introns as mobile genetic elements, Annu. Rev. Biochem., 62, 587, 10.1146/annurev.bi.62.070193.003103 Le, A.D., Ko, J., Chow, S. and Quan, B., Alcohol consumption by C57BL/6, Balb/c and DBA/2 mice in a limited access paradigm, Pharmacol. Biochem. Behav., 47 (19??) 375–378. Lin, 1993, Simple and rapid sample preparation methods for whole blood and blood plasma, 605 Little, 1988, Pharmacology and stereoselectivity of structurally novel cannabinoids in mice, J. Pharmacol. Exp. Ther., 247, 1046 Maniatis, 1991, Mechanisms of alternative pre-mRNA splicing, Science, 251, 33, 10.1126/science.1824726 Martin, 1986, Cellular effects of cannabinoids, Pharmacol. Rev., 38, 45 Martin, 1994, Cannabinoid receptors: pharmacology, second messenger systems and endogenous ligands, NIDA Res. Monograph, 140, 55 Martin, 1993, Antinocicetive actions of cannabinoids following intraventricular administration in rats, Brain Res., 629, 300, 10.1016/0006-8993(93)91334-O Matsuda, 1993, Localization of cannabinoid receptor mRNA in rat brain, J. Comp. Neurol., 327, 535, 10.1002/cne.903270406 Matsuda, 1990, Structure of a cannabinoid receptor and functional expression of the cloned cDNA, Nature, 346, 561, 10.1038/346561a0 McClearn, 1959, Differences in alcohol preference among inbred strains of mice, Q. J. Stud. Alcohol., 20, 691, 10.15288/qjsa.1959.20.691 McClearn, 1959, Genetic factors in alcohol preference in laboratory, J. Comp. Physiol. Psychol., 20, 691 Munro, 1993, Molecular characterization of a peripheral receptor for cannabinoids, Nature, 365, 61, 10.1038/365061a0 O'Dowd, 1993, Structures of dopamine receptors, J. Neurochem., 60, 804, 10.1111/j.1471-4159.1993.tb03224.x Okuda, 1986, Hypothalamic control of pituitary and adrenal hormones during hypothermia, Psychoneuroendocrinology, 11, 415, 10.1016/0306-4530(86)90003-X Onaivi, 1990, Pharmacological characterization of cannabinoids in the elevated plus maze, J. Pharmacol. Exp. Ther., 253, 1002 Onaivi, 1992, Approaches to the determination of the central sites of action of cannabinoids, Soc. Neurosci. Abstr., 18, 157.7 Onaivi, 1992, Comparison of behavioral and central BDZ binding profile in three rat lines, Pharmacol. Biochem. Behav., 43, 825, 10.1016/0091-3057(92)90414-B Pellow, 1985, Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat, J. Neurosci. Methods, 14, 149, 10.1016/0165-0270(85)90031-7 Pertwee, 1991, Drugs which stimulate or facilitate central cholinergic transmission interact synergistically with delta-9-tetrahydrocannabinol to produce marked catalepsy in mice, Neuropharmacology, 30, 67, 10.1016/0028-3908(91)90044-C Pertwee, 1972, The ring test: a quantitative method for assessing the cataleptic effect of cannabis in mice, Br. J. Pharmacol., 46, 753, 10.1111/j.1476-5381.1972.tb06900.x Rio, 1992, RNA binding proteins, splice site selection, and alternative pre-mRNA splicing, Gene Expr., 2, 1 Rosenfeld, 1993, Reversible tetracaine block rat periaqueductal gray (PAG) decreases baseline tail-flick latency and prevents analgesic effects of met-enkephalin injection in nucleus paragigantocellularis (PGC), Brain Res., 605, 57, 10.1016/0006-8993(93)91356-W Roth, 1979, The non-specific membrane binding properties of Δ9-THC and the effects of various solubilizers, J. Pharm. Pharmacol., 31, 224, 10.1111/j.2042-7158.1979.tb13484.x Sambrook, 1989 Shibata, 1989, Effect of benzodiazepine and GABA antagonists on anticonflict effects of antianxiety drugs injected into the rat amygdala in a water lick suppression test, Psychopharmacology, 98, 38, 10.1007/BF00442003 Slotnick, 1975 Smolen, 1986, A strain comparison of physiological and locomotor response of mice to diisopropylfluorophosphate, Pharmacol. Biochem. Behav., 24, 1077, 10.1016/0091-3057(86)90458-2 Yadin, 1991, Anxiolytic effects of benzodiazepines in amygdala-lesioned rats, Psychopharmacology, 103, 473, 10.1007/BF02244247